ABSTRACT
As a model for Neuropsychiatric dysfunction in NeuroAIDS due to HIV-1 infection and drug abuse, we analyzed gene expression in human neurons treated with cocaine and HIV-1 proteins tat and envelope (env). Oneway ANOVA showed statistically significant genes among the treatment groups (p ≤ 0.0005). The identified genes were then subjected to a "stepwise" analysis using a repeated measures ANOVA to discover genes with parallel response group profiles across the treatment conditions. These groups were then analyzed using a repeated measures ANOVA to assess treatment main effects and gene-by-treatment interactions within groups. One-way ANOVA produced 35 genes that were significantly associated across all treatment conditions. Factorial analysis of each gene found statistically significant differences: 30 -tat, 17 -cocaine, 10 -env, 6 -tat/env, 6 -coc/env, and 4 -coc/tat. Analyses across genes found three sets of four genes, one set of three genes, and three sets of two genes with parallel profiles. Identified genes had functions included signaling, immune related, and transcription control. The genes were not stochastically arranged on the chromosomes, were in proximity to each other, and to other genes involved in neuropsychiatric diseases. We hypothesize that these genes fall in transcriptionally isolated groups and that abused drugs and HIV-1 proteins trigger transcription overload, coerced expression that may result in damage to the chromosome's control and organization of chromatin transcription machinery.
INTRODUCTION
An important rationale for our studies is that drug abuse is a complicating factor in the progression, diagnosis, and treatment of NeuroAIDS as well as AIDS (1) . Thus, we commenced the current study of gene expression in neurons in cultures treated separately and in combination with cocaine and HIV-1 tat and env proteins. A central focal issue in drug abuse research with human populations compared to cell culture and animal studies is that humans for the most part select poly-drug use whereas specific drugs can be tested in cell culture and animal studies. Thus, a further complication in determining the mechanisms of drug addiction, drug effected pathways that lead to behavioral and organic pathology as well as HIV-1 infection is to extricate the effects of drugs including cocaine, methamphetamine, opiates, and the product of cocaine/ethanol ingestion, cocaethylene given the new technologies of Microarrays for gene expression. There are thus several factors including drug abuse and HIV-1 infection that interact to produce NeuroAIDS. The analysis of the details of these factors is vital in the development of paradigms for prevention and cure of NeuroAIDS. These are discussed briefly here.
AIDS Dementia
Cocaine abuse has been an impediment for constructive social development for many years and continues to be a growing problem in the United States. Since the last century, there has been a steady increase of cocaine abuse in the United States. From 1999 to 2002 cocaine was the most common drug reported in emergency department visits (2). Cocaine abusers were treated more frequently from ages 18 to 25. In 1999, the Office of National Drug Policy estimated that there were 3.6 million chronic cocaine users (3) . According to the National Household Survey on Drug Abuse in 1997, the prevalence of cocaine use was 1.4 percent for African American, 0.8 percent for Hispanic, and 0.6 percent for Caucasian populations in the US.
HIV-1 penetrates the blood-brain barrier (BBB) early in the course of HIV-1 infection (4, 5) and causes brain damage (e.g. cerebral atrophy) (6) . Further studies describe HIV-1 evolution in the brain compartment. An initial study showed HIV sequences were present in AIDS cases with dementia (7) . HIV-1 infected monocyte/macrophages and microglia, and macrophagetropic HIV-1 strains are associated with neurologic disease more than T-cell tropic isolates (8) . HIV-1 may evolve divergently and separately in different regions of brain in NeuroAIDS (9, 10) . Some recent studies showed that HIV sequences from deep white matter had greater similarities with bone marrow derived sequences than with other tissue or fluids. The implication is that there is frequent trafficking of monocytes from bone marrow into the brain associated with late stage dementia. A hypothesis was advanced that this is a process for late-stage HIV-1 penetration of the brain (11) . During late-stage AIDS, CD16 expression increases on macrophage-monocytes that exit bone marrow due to increased M-CSF in the bone marrow. Furthermore, in late stage infection, when blood monocytes circulating in the activated state meet brain microvasculature endothelium, they are able to initiate the changes that lead to transmigration. This process then enhances additional macrophage/monocyte recruitment. HIV-1 infection of the brain further accelerates this incursion. Thus, in this model, intrusion of new virus strains occurs continually prior to death via cycles of augmented macrophage/monocyte trafficking into the brain from bone marrow (12) .
Pathological studies have elucidated several components in NeuroAIDS pathogenesis. Infected macrophage and microglial cells may be the primary conduit for HIV-1 invasion of the brain. In addition, astrocytes and neurons may be infected as well (13, 14) . In situ immunohistochemical and hybridization studies on sections from autopsied AIDS brains in many laboratories detected HIV-1 at high frequency in macrophage and microglial cells (13, 15, 16, 17) and in association with multinucleated giant cells and microglial nodules, This complex set of processes and pathology is termed HIV Encephalitis (HIVE) (18, 19, 20) .
Inflammation
Inflammatory cytokines as well as other inflammatory molecules are associated with brain inflammation and damage including IL-1, IL-6, TNF-α, IFN-γ, arachidonic acid, and PAF (21, 22) . In addition, IFN-γ and TNF-α activate macrophages that produce excitatory compounds including quinolinic acid and reactive oxygen (e.g. nitric oxide, NO) (23, 24, 25, 26, 27, 28) . Moreover, the production of chemokines (CCKs) further increases the dimension of the inflammatory condition. Several CCK receptors are on brain cells including macrophages and neurons thus furthering the impact of inflammation. MCP-1, MIP-1, and RANTES are produced that activate macrophages thru CCR5, SDF-1a binds to CXCR4, and fractalkine binds to CX3CR1 further mediating macrophage recruitment into the brain (27, 29) . This is confirmed in the use of animal models; for example, the SCID mouse injected with HIV-1-infected human macrophage/monocytes demonstrated brain inflammation related to their level of virus replication and the presence of these cells (30) . Of many animal models, the SIV-rhesus macaque also yields important information related to NeuroAIDS disease (31, 32) . The monkey animal model using SIV recapitulates NeuroAIDS in great part (33) and infection of CNS is supported by animal model studies as well. A neurovirulent clone of SIV was isolated that causes CNS lesions. Coinfection with an immunosuppressive clone further exacerbates neural disease (34).
Neuronal damage
Neuronal injury and cell loss (neurotoxicity) are hypothesized to result from toxic mechanisms that are initiated and maintained by productive HIV-1 infection in the CNS directly involving several HIV-1 proteins and indirectly by factors produced by activated and inflamed brain cells (20, 35) . This damage may vary across brain regions or compartments (36) . Damage closely associated with HIVE occurs to specific subpopulations of neurons in neocortex, limbic system, and basal ganglia (18, 20, 37) .
Microglial cells in specific brain regions may be more vulnerable to HIV-1 infection than in other regions (38) . These processes may involve specific subpopulations of macrophage/microglial cells (39, 40) and specific regionalneurotropic mutations of HIV-1 (9, 10, 41) . Alternate models have been proposed as well. For example, it was proposed that in macrophage-derived cells co-evolution of the viral LTR, tat, and Vpr are associated with HIV associated dementia (HAD) (42) . In addition, elevated nitric oxide synthase levels were demonstrated in neurons in AIDS sensory ganglia and in neurons from patients who were HIV infected and cocaine users (26, 43) . In summary, severity of HIVE and HAD may be associated with neuronal cell death caused by abnormal activation of the immune system induced by infection of a specific subpopulation of macrophages or microglial cells by neurovirulent subset quasispecies of HIV-1 evolving specifically in local brain regions.
Drugs, HIV-1, neural cells, and NeuroAIDS
Cocaine abuse results in clinical signs and symptoms that include immunologic, behavioral, and neurophysiologic complications and deficits. Cocaine's stimulatory and addictive effects in great part result from its well-characterized ability to inhibit neuronal reuptake of dopamine. Cocaine has pleiotrophic effects, however, and for example enhances the production of IL-6. IL-6 is known to stimulate HIV-1 replication and is produced by the stimulation of mononuclear and astrocytes that may be important to the progression of HAD (44) . In addition, behavioral and neurological studies in conjunction with brain PET scans further indicate that cocaine has a detrimental effect on brain function. For example, it was established from PET scans that cocaine reduces cerebral blood flow in anterior cortical areas beyond normal vasoconstriction (45) . Additionally, cocaine stimulates the CNS and acts as a strong behavioral reinforcer. Long-term cocaine abusers develop paranoia, delusions, and various disorders. Furthermore, chronic users tend to be in a higher risk for stroke, heart attacks, and pneumonia (46) . Cocaine causes deficits in many neuropsychological areas including attention, concentration, learning, verbal memory, information processing speed, and calculations (46) .
There are some indications of co-incidences of cocaine and amphetamine epidemiology but additional studies need to be performed more extensively to investigate that possibility (38, 47) . Mechanistically, cocaine-and methamphetamine-mediated CNS damage appear to be related. There is cross-sensitization between the two drugs in mice (48) . The mechanism of this effect may be in part related to NMDA and NOS (49) . Further studies indicate that just as with cocaine, amphetamine administration in conjunction with HIV-1 tat results in combined toxicity to neurons. Mitochondrial alterations were found in a non-pyramidal Calbindin positive human cultured neuron cell line due to dysregulation of calcium potential in mitochondria of these neurons (50.) In terms of drug treatment paradigms, it is interesting to note that buprenorphine was effective in reducing self-administration of cocaine, heroin, and cocaine/heroin "speedballs" whereas amphetamine was effective in reducing selfadministration of cocaine and cocaine/heroin "speedballs" (51) .
HIV-1 protein and drug treatments as well as HIV-1 infection of neural cells resulted in changes in several genes. A few examples follow. Early studies pointed toward calcium and glutamate channel involvement in gp120 toxicity. Treatments of postnatal rat retinal ganglion cell neurons with gp120 concentrations of 2 to 200 pM up to10 minutes increased Ca +2 in these cells (52) . Lipton (53) found that 2 uM memantine prevented the injury produced by 20 pM gp120. Nath et al (54) showed that env and tat HIV-1 protein damage of neurons could be reversed by memantine. In Calbindin-containing neuron cultures exposed to gp120 (at 100 pM) for 24 hr, initially neuronal survival was 19.7% and 84.6% in control cultures (55) . 200 pM gp120 causes a significant accumulation of reactive oxygen species (ROS), including superoxide and accumulation of lipid peroxidation in primary hippocampal cultures (56) . Rat cerebellar granule neuron cultures of 7-8 days were exposed for 15 minutes to a buffered Locke's solution containing 100 pM gp120, washed, and cultured for an additional 24 hours in their original medium. The control culture average cell death was 8% and gp120 treatment (1 pM-10 nM) caused an increase of cell death of approximately 80%. There was a lack of neurotoxic effect of media conditioned by astrocyte-enriched and by granule cell cultures, pre-exposed to gp120 or glutamate for 15 minutes (57). Cytotoxic effect induced by 10 pM gp120 in CHP100 human neuroblastoma cells was inhibited by ethanol exposure (58) . Rat cortical astrocytes, human glioblastoma cells and glial restricted precursor cells, from a human embryonic terato-carcinoma cell line, were incubated with recombinant tat (100 ng/ml for 60 minutes) that induced a significant reduction of glutamate or ATPinduced intracellular Ca 2+ increase (59) . An unusual finding is that at a lethal cocaine concentration (100 ug/ml), there were no affects on neuron proliferation or cell morphology (60) . In a relevant study in non-neural cells, human mesangial cells (HMC) were treated with gp120 in different doses (0-800 pM) for 16 hr. At lower concentration (800 aM) gp120 promoted and at higher concentrations (800 pM) gp120 suppressed the proliferation of HMCs (61) . Consequently, the effects of HIV-1, its pure proteins, with and without abused drugs including cocaine, are complex and vary under the experimental conditions. Thus, additional work is required to further increase our understanding of these complex phenomena.
It is important to note that there may be overlapping pathways among several different types of abused drugs and this is under investigation. Morphine stimulates SIV replication in monkeys and cocaine stimulates SIV levels as well (34, 62) . Kappa agonists inhibit cocaine-induced HIV-1 expression in human microglial cells by suppression of ERK (63) . Human microglial cells were infected with HIV-1 SF162, an R5 isolate, and viral expression was quantified by measurement of p24 antigen in culture supernatants. KOR ligands inhibit cocaine's stimulatory effect on viral expression involves the suppression of cocaine-induced activation of extracellular signal-regulated kinase1/2 thereby blunting cocaine-enhanced up-regulation of the HIV-1 entry chemokine co-receptor CCR5. The findings of this study suggest that in addition to its neurotoxic effects, cocaine could foster development of HAD by potentiating viral expression in the brain, and that this phenomenon is inhibited by KOR ligands (63) . In addition, Memantine, a possible therapeutic agent for NeuroAIDS protects neurons exposed in vitro to HIV-1 tat and env (54.) Cannabinoids modulate immunity, through the T celldendritic axis and result in a shift of TH1 to TH2 patterns (64).
MATERIALS AND METHODS

Neuron isolation and culture
Brain specimens were obtained from human fetuses of 12-14 weeks gestational age with consent from women undergoing elective termination of pregnancy (all IRB and NIH rules and regulations were strictly enforced). Neuronal cultures were prepared as described previously (65, 66) . Briefly, the cells were mechanically disassociated, suspended in OPTI-MEM medium with 5% heatinactivated fetal bovine serum, 0.2% N2 supplement (GIBCO) and 1% antibiotic solution (penicillin G at 104 units/ml, streptomycin at 10 mg/ml, and amphotericin B at 25 ug/ml) and plated in flat bottom flasks. The cells were maintained in culture for at least one month prior to conducting the experiment.
At the time of culture treatments, the culture medium was replaced with Lock's buffer containing 154 mM NaCl, 5.6 mM KCl, 1 mM MgCl2, 3.5 mM NaHCO3, 5 mM D-glucose, 5 mM N-2-hydroxy-ethyl-piperazine-N'-ethanesulfonic acid (pH 7.2). Each of the eight culture treatments was done in triplicate: medium alone, medium with tat, env (gp120), cocaine, tat and envelope, cocaine and envelope, cocaine and tat, and tat and cocaine and env. HIV-1 tat was used at 80 nM, env at 30 pM, and cocaine at 1.6 uM and the duration of the incubations was 6 hours. All dosages were at subtoxic concentrations (65, 66, 67, 68) .
Recombinant tat was prepared as described previously (67) with minor modifications. The tat gene coding for the first 72 amino acids was amplified from HIVBRU (obtained from Richard Gaynor [Galveston, TX]) through the AIDS repository at the NIH and inserted into vector PinPoint Xa-2 (Promega) and grown in E. coli HB101. HIV-1SF2 gp120 (originally isolated from a patient with HIV associated neurological disease) was obtained as a gift from Chiron Corporation. The tat and env proteins were shown to be 95% free of degradation products by Western Blot and free of endotoxin (< 1 pg/ml) as determined by Pyrochrome Chromogenic test kit (Associates of Cape Cod Inc, Falmouth, MA). The proteins were aliquoted and cryopreserved at -80 o C in aqueous stock solutions in endotoxin-free siliconized microfuge tubes prior to use.
Gene Expression Analysis
Cell cultures were rinsed with Locke's buffer and total RNA extracted from 3-4 million cells per culture using Trizol reagent (Invitrogen). The RNA yields ranged from 11.75 to 77.05 ug per culture. RNA was amplified using Arcturus labeling kits (Arcturus). The Affymetrix HGU95A oligonucleotide chip was used to measure the expression of over 12,565 probes. The primary data were processed using Affymetrix Microarray Suite version 4.0 (MAS 4.0) followed by further analysis. Affymetrix gene identification and description are based on NetAffx Analysis Center (69).
Statistical Analysis
We performed a one-way ANOVA between the eight treatment groups across genes (no treatment control, tat alone, envelope alone, cocaine alone, tat-envelope, tatcocaine, envelope-cocaine, and envelope-tat-cocaine.) We then selected the genes for which the ANOVA was statistically significant at α = 0.0005 and 35 genes fulfilled this requirement. Assuming independence across the genes, under the null hypothesis we would expect to find only six genes significant (e.g. we expect to make six Type I errors). Thus, we have identified many more genes than would be expected due to chance. Each of the identified genes was then analyzed further in an ANOVA across the 2x2x2 factorial arrangement of treatments. Primary factors are coc, env, and tat; potential interactions are coc-tat, cocenv, tat-env, and coc-tat-env.
Next, gene expression profile analysis of the 35 genes was done. Starting with the first gene in the list, a repeated measure ANOVA was performed with each remaining gene and any pair of genes that was judged to be "parallel" was noted. This pair was then analyzed with each remaining gene to find statistically parallel triples. Triples were then analyzed with each remaining gene, and similarly for quadruples. A group of genes was defined to be jointly parallel if their gene by group interaction was not significant at p ≤ 0.05. This process yielded three sets of four genes each, one set of three genes, and three sets of two genes each, such that the response profiles within each set were parallel. There were no gene-combinations with more than four members and fourteen genes remained ungrouped.
Each set of parallel genes was then analyzed in a repeated measure ANOVA with three grouping factors and one repeated factor. The grouping factors were each at two levels in a 2x2x2 factorial arrangement: tat (with, without), envelope (with, without), and cocaine (with, without). The repeated factors were the genes within the set being analyzed. Further analysis was done as follows. The 'among-treatments' analysis included the treatment main effects and the two-factor treatment interactions, while the 'within-treatments' analysis included gene effects and the two-factor and three-factor gene interactions with treatments. The SAS statistical program PROC GLM (SAS Institute Inc, Cary, NC) was used for all analyses.
Gene-Chromosome and Pathway Analysis
The web sites used for gene identification and chromosome mapping were as follows. http://hal.hgc.jp/cgibin/gene_ensembl.cgi?id=ENSG00000157349.4 http://human.genelynx.org/cgibin/record?glid=9366&submit=Go 
RESULTS
Gene Identification
Thirty-five genes were identified in the neuron treatment experiments using one-way ANOVA (70) . Table  1 shows the Affymetrix identifications, abbreviations, and functions of each of the 35 genes. This table also contains the observed significance values (i.e. p-values) of the overall test of model usefulness for each gene, as well as those for the main effects and interactions (association of each gene with each treatment condition). A blank cell indicates no significant association. There are significant effects with primary factors as follows: 30 genes with tat, 17 genes with cocaine, and 10 genes with env. Several genes show main effects with more than one primary factor. Thus, 10 genes are significant with tat and env, four with env and coc, and 12 with tat and coc. Of these, four genes show significant effects due to all three primary factors. Of four genes that showed no effects due to tat, one had effects due to coc and tat-env, and three due to cocaine alone.
Significant interactions are as follows: 6 with tatenv, 6 with coc-env, 4 with coc-tat, and none with tat-envcoc. One gene shows effects with 2 interactive factors tatcoc and tat-env. One gene shows effects with all three interactive factors coc-env, tat-coc, and tat-env.
Several genes showed effects due to primary and interactive factors as follows: 6 with tat and env-coc, 3 with tat and tat-coc, 5 with tat and env-tat, 3 with tat and coc and env-coc, 4 with coc and env-tat (of these one included tat and tat-coc, and two with tat and env), 2 with tat, coc, and tat-coc, 2 with tat, env, and env-coc, 1 with tat, env, and tat-coc, 3 with tat, env, and env-tat. One gene showed effects due to tat, coc, tat-coc, and tat-env, one due to tat, env, coc, and tat-env, and one due to tat, env, tat-coc, envcoc, and tat-env.
The search for gene-sets with similar response profiles across treatment groups yielded three sets of four genes each, one set of three genes, and three sets of two genes each (Figures 1-7) . The remaining fourteen genes each reflected unique 'hermit' profiles. In these figures, the y-axis label represents gene expression intensity. The xaxis labels are T (tat), E (env), C (cocaine), their combinations, and None (no treatment). The genes are Table 2 . T = tat, E = env, C = cocaine Table 2 . T = tat, E = env, C = cocaine Table 2 . T = tat, E = env, C = cocaine Table 2 . T = tat, E = env, C = cocaine Table 2 . T = tat, E = env, C = cocaine 
Gene groups
The gene sets shown in Table 2 resulted from the analyses designed to discover whether the response profile across treatment for each individual gene was essentially parallel to the response profiles of one or more of the other selected genes. The p-values shown in the table are with respect to the factorial arrangement of treatments in a repeated measures ANOVA to test whether the responses to tat, env, and coc were significant when pooled across the gene set and whether the responses to tat, env, and coc were similar across the genes within the set. The particular interest in this analysis was whether the effect of the individual treatments is different across the genes as measured by the tat-gene, env-gene, and coc-gene interactions. Gene groups 1-7, (three quartets, one trio, and three duos) correspond to figures 1-7, respectively. Tat has a significant effect for groups 1-7. In addition, env and coc are each significant factors for group 7, coc is a significant factor for groups 5 and 6, and coc shows a trend for group 2. There is at least one significant gene by treatment interaction within all parallel gene groups except for group 5. These interactions indicate that the individual genes within the parallel group are responding differently to the specific treatment. Most of the interactions are with tat. There is a trend for tat-gene interaction for group 1 and groups 4-6 show significant tat-gene interactions. There is only one significant interaction for env-gene (group 3) and two for coc-gene in groups 2 and 7.
For the identified 35 genes, Table 3 shows the Affymetrix IDs, the standard abbreviations, the HUGO site IDs, and a few of the salient functions of these genes. One gene identified by Affymetrix location (937_at) did not have any other abbreviation (although it was stated to be a G1-phase specific protein) and was not used in subsequent analyses.
Pathways
The Ariadne program was used to examine possible gene interactions based on transcription, translation, and signaling as well as location in the cell including nucleus, cytoplasm, mitochondrion, Golgi, and cell membrane (Figure 8) . Genes within each statistical groups 1-7 were distributed among the various protein locations in the cell.
Colors and cell location representations are respectively red -cell membrane, pinkcytoplasm, blue -mitochondrion, and green -nucleus. All 34 genes were used for pathway analysis as were each of the 7 grouped and the ungrouped 'hermit" genes. Many genes showed direct pathway connections and those that did not may have 2 nd order or higher pathway connections (analysis not shown). Many genes in statistical groups showed pathways connections (groups 1, 2, 4, and 7) and some genes did not (groups 3, 5, and 6). Examples of pathways produced by Ariadne are shown in Figures 9 and 10. Figure 9 shows that 11 of the 34 genes did not have any direct interconnections among these genes. This figure also shows that the genes in the pathways and interconnections include functions such as differentiation, growth, secretion, maturation, signaling, and mRNA processing. The genes that are in statistical groups 1-7 also have various degrees of pathway interaction. The genes that are in pathways in each group are respectively 3 of 4 genes in Group 1, 3 of 4 genes in Group 2, 0 of 4 genes in Group 3, 3 of 3 in Group 4, 0 of 2 in Group 5, 0 of 2 in Group 6, and 2 out of 2 in Group 7. Of the 15 ungrouped 'hermit' genes, 9 showed direct pathway interconnections. Figure 10 is an example of genes that are in direct interactive pathways and shows interactions among discoidin domain receptor tyrosine kinase signaling (DDR2), immediate early transcription factor (JUNB), and uridine phosphorylase 1 (UPP1). DDR2 and JunB also interact with matrix metalloproteinase 1 (MMP1) involved in the breakdown of the extracellular matrix and cell growth. They also interact with the SRC gene that is involved in cell growth. Table 4 shows the results of a calculation of the possible stochasticity of the occurrence of the 34 Affymetrix-identified genes per human chromosome. A Chisquare statistic was calculated comparing the expected and observed numbers of genes per chromosome. The expected number of genes/chromosome was taken as 34 genes/24 chromosomes = 1.416. The Chi-square was 38.11, with 23 degrees of freedom, p = 0.0248. To verify the adequacy of the Chi-square statistic a Monte Carlo simulation was carried out. It was assumed that the elements (genes) are distinct and that there was no exclusion, i.e. that any number of the 34 genes could be located on any chromosome (Maxwell-Boltzmann statistics), with the probability that any chromosome would be selected at each trial equal to 1/24= 0.04167. The calculations were reiterated 5,000 times using the SAS function RNTBL. A quantile-quantile plot of the cumulative frequency distribution against the theoretical 23-df Chi-square showed virtual identity between the simulated and theoretical distributions. Thus it is concluded that the distribution of the identified genes across chromosomes is not random at p ≤ 0.0248. Table 5 shows the 35 genes, their chromosome locations in the human genome, absolute nucleotide number locations on each respective chromosome, their lengths, the chromosome lengths on which they fall, and their % length compared to the respective chromosome length. Table 6 tabulates the genes that appear on each of the human chromosomes (22 autosomal and two gender chromosomes), and other relevant disease genes on both p and q arms of each chromosome. Analysis of the number of genes (identified in the current study) that occur on each human chromosome showed that six chromosomes had none, nine chromosomes had one gene, three chromosomes had two genes, two chromosomes had three genes, three chromosomes had four genes, and one chromosomes had five genes. This is highly divergent from a stochastic distribution of the genes across the human chromosomes. When more refined structure maps are examined then several genes are found not only on the same chromosome arm but also located in proximity. For example, MAT2A is at 2p11.2, KIAA0582 at 2p14, ARHB at 2p12, HS6ST1 at 2q21, and MAP2 at 2q34-q35. JUNB, RNF126, LOC51257, and MGC10471 are located at 19p13.2, 19p13.3, 19p13.3, and 1913.3-p13.1 respectively. Table 7 shows a brief synopsis of genes that are associated with neuropsychiatric diseases on the human genome. Each of the 34 identified genes in our study is on a chromosome with neuropsychiatric diseases as shown in Tables 6 and 7 . Table 8 shows the distribution of the identified genes among several categories. The neuropsychiatric category contains 17.1% of the genes, transcription 28.6%, signaling 11.4%, neuronal synapse 8.6%, proteasome 5.7%, cell surface function 5.7%, metabolism 14.3%, and genome maintenance, ion channel, cell cycle, electron transport, RNA & viral RNA induced, and nuclear pore each 2.9%.
Gene Chromosome maps
DISCUSSION
Gene expression in drug abuse and NeuroAIDS
In a classical study comparing frontal cortex from patients with HIVE vs. controls, Masliah et al (71) showed that 74 genes were down-regulated and 59 genes were upregulated out of 12,625 genes analyzed. Down-regulated genes included cytoskeletal components, transcription factors, signaling, cell cycle, synaptic transmission, and synaptic plasticity. Upregulated genes included cytoskeleton transcription, signaling modulation, anti-viral response, and neuroimmune response. These results were directly translated into a model of Neurotoxicity subsequent to HIV-1 infection of the brain with neuronal effects due to the categories as listed. And indeed many studies have been performed using the two-way approach comparing cases and controls (72, 73.) We have recently performed gene expression studies related to AIDS dementia using other statistical methods (22, 26, 40, 70, 74, 75) . Overall, similar classes of genes were implicated in these studies although not precisely identical genes across all studies. This is an important issue since it seems unlikely that the current state of the art of statistical analysis will implicate precisely identical genes across studies with different patients, tissues, and methods.
In the current preliminary analysis of human neuron gene expression in culture, results using the oneway ANOVA produced a list of 35 genes that were significant across treatments. Subsequent application of a HTATSP1 Xq26.1-q27.2 HIV-TAT specific factor 1, GJB1 Xq13.1 (CharcotMarie-Tooth, neuropathy) Y GLM analysis to individual genes for significant interactions indicated most genes were significant due to tat, some due to tat-env, tat-cocaine, and env-cocaine interactions and none due to tat-env-cocaine interactions. The analysis of gene expression data in the literature has predominately taken the approach of conceptually transposing the observed data so that the genes being probed become experimental units (i.e. "subjects") and the samples, cultures, or human subjects become the "variables" in the analysis. This has been done mainly because the number of gene probes (e.g. Affymetrix chips with 12,565 to 40,000 probes and CodeLink chips with 55,000 gene sequences) is so much larger than the number of samples that the conventional methods of Multivariate Analysis of Variance (MANOVA) or its analogues cannot be applied (76) . However, an alternative statistical approach, the repeated measures ANOVA can be applied which takes into account the correlated nature of gene responses within subject (77) . This approach has been recommended by Emptage et al (78) in their treatment of microarray experiments as split-plot designs.
In this neuron study we tested eight different neuron cell culture conditions that were composed of three treatments (tat, envelope, cocaine), each at two levels (present, absent) in a factorial arrangement. This yields eight (2x2x2 = 2 3 ) different conditions. The first analysis was to discover individual genes for which the response was significantly different across the eight treatment conditions. We used an ANOVA and selected a low probability (p < 0.0005) in order to obtain a feasible number of genes to analyze further. This is similar to examinations including cluster analysis and principal components analysis (PCA) to produce a manageable number of genes indicative of treatment differences. In this manner we found 35 genes that show a significant response across the 8 treatment conditions. In order to further characterize the significant differences among conditions, the response of each selected gene was analyzed in a factorial ANOVA, testing the primary factors tat, (as previously defined) envelope (env), and cocaine (coc) and their two-factor interactions tat-env, tat-coc, and env-coc. Thus, the results in Table 1 support the strength of effects on gene expression by tat, cocaine, and env (in decreasing order.) These three treatments show interactive effects. However, genes such as CD44 (cell-surface glycoprotein involved in cell-cell interactions, cell adhesion, and migration), SDC2 (syndecan 2, heparan sulfate proteoglycan 1, cell surface-associated, fibroglycan, also a receptor for both Fibroblast Growth Factor-2 (FGF-2) and β-amyloid), and ARHB (Aplysia ras-related homolog, small guanosine triphosphatase Rho regulates actinfilament remodeling), although they have tat and env primary effects do not show any interactive effects with tatenv. This phenomenon is true for a few additional genes including tat and coc primacy effects for genes HS6ST1 (a heparan sulfate biosynthetic enzyme, thus related to SDC2 mentioned above) and tat, coc, and env primary effects for MAP2 (microtubule-associated protein related to neurofilaments and dendrite remodeling and thus related to ARHB mentioned above) but only an interactive effect with tat-env for this gene (MAP2). The possible explanation for this phenomenon is that for genes where the primary effects and interactive effects do not match may be due to a cancellation mechanism in the over-all networks of the neuronal homeostatic machinery. This is an important phenomenon because when we extrapolate to actual mechanisms in brain where the panoply of reactions is orders of magnitude more complex, cancellation and stimulation interactions among the pathways are to be expected. In reference to SDC2 mentioned above, it should be noted that mechanistically that Heparan Sulfate serves in a neuroprotective role as a binding site for FGF-2 and in a neurodamaging role as a binding site for β-amyloid fibrils (79) .
Laboratory findings support the notion of cancellation treatment effects. In work focusing on cocaine related effects on HIV-1 replication, in vitro, we have previously shown that two primary conditions that effect HIV-1 gene expression do not result in an additive interactive effects, although additive interactive effects were expected. Thus, cocaine and cocaethylene each stimulate HIV-1 reverse transcriptase gene expression in HIV-1-infected normal donor PBMNC cultures but their interactive effect actually results in a 3-fold suppression of HIV-1 reverse transcriptase gene expression. In the same study, ethanol treatments restored stimulation of HIV-1 gene expression in a mixture of cocaine, cocaethylene, and ethanol (80, 81) .
Even prior to the current widespread use of Microarray studies, approximately 103 genes were identified with altered expression after drug administration as of 2001 (82) . One of the goals in this type of work related to the pathobiology of drug abuse is to establish a causal relationship between drug abuse and genes beyond genetics. An example is a protein termed CART -cocaine and amphetamine regulated transcript. This protein responds to psychostimulant drug administration and is remarkable. When CART peptides are injected into the rodent ventral tegmental area, the resulting behavioral changes include pharmacologic psychostimulant-like effects (82) .
Thus, in the current study, a few examples of genes, their drug and HIV-1 protein treatment interactions, and their pathways for pathogenesis follow. The expression of two ungrouped 'hermit' genes, MAP2 and KREMEN2, are each associated with tat, env, coc, and tat-env treatments. These combinations result in effects on these genes even though they are not in any of the 'grouped' genes. They are however interrelated functionally as follows, though. The gene MAP2 is the microtubule associate protein-2 and is involved in neuronal intracellular filament assembly. KREMEN2 is Kringle containing transmembrane protein-2. This protein is a high-affinity dickkopf homolog 1 (dkk1) trans-membrane receptor that functionally cooperates with dkk1 to block wingless (wnt)/β-catenin signaling. Furthermore, β-catenin and its regulatory kinase, GSK-3 beta, (also known as MAP-tau protein kinase-1) are associated with activity of presenilin-1 (PS-1) (83.) Perturbation of β-catenin integrity may lead to hyperphosphorylation of MAP-tau and neurofibrillary tangle formation (NTF) and to neuronal apoptosis via different signaling pathways (83, 84, 85, 86, 87, 88, 89) . It should also be noted that Disrupted-in-Schizophrenia-1 (DISC1) was identified as a potential susceptibility gene for Schizophrenia and was shown to co-localize with MAP2 in neurons of the olfactory bulb, cortex, hippocampus, hypothalamus, cerebellum and brain stem (90.) Thus, perturbation of MAP2 gene expression due to the drug and HIV-1 protein treatments may perturb the activity of DISC1 and further exacerbate neuronal dysfunction.
Another example is the interactions among genes mentioned above, DDR2, discoidin receptor that is a tyrosine receptor kinase, JUNB an immediate early transcription factor crucial in gene expression control in neurons (as well as in other cells), and UPP1, uridine phosphorylase 1. These genes show pathway interactions related to growth cytokine (inflammation), and matrixmetaloproteinase (MMP) activities and thus may be indicative of repair or restorative responses of the neuron related to the cocaine, HIV-1 tat, and envelope treatment effects.
An additional example of a gene identified in our study that shows novel regulatory mechanisms is TM4SF1. Expression of this gene is associated with tat and env-coc treatments. TM4SF1 (Transmembrane 4 superfamily member 1) is a tetraspanin family cell surface signaling structural raft-related protein. The mechanism of tetraspanin family proteins in signaling and their association with HIV-1 proteins in the immune synapse is under recent study (91, 92) . This protein may be related to presentation of HIV-1 proteins; thus, the perturbation in its expression due to tat and env-coc treatments may play an important role in the ability of immune surveillance to screen cells expressing HIV-1 proteins.
Hypothesis 1. Genes identified related to drug abuse and HIV-1 protein treatments are associated with transcription isolation
The genes identified in our studies are related among several different levels of analysis, dimension, or category. There is some molecular basis for the statistical analytic results for several of the genes through Ariadne analysis as well as identification of their chromosome grouped locations. This is remarkable in that the statistical analyses are done by computer programs with no abrogation of objectivity during the analysis, since the programs run and analyze the data in a 'black box' mode. Furthermore, the associations of several genes in groups occur on the same chromosome, chromosome arm, and in proximity on the chromosome arm. This supports functional, pathobiological, and pharmacologic associations for the genes. For example, the gene we identified as KIAA0478 is in the same karyotype band 1p36 as HTR1D, a serotonin receptor. These are furthermore near PARK7 or DJ-1, an early onset Parkinson's disease gene. DJ-1 is a chaperone protein with anti-oxidant function. An additional example is that a few identified genes on chromosome 2 (MAT2A at 2p11.2, KIAA0582, and ARHB, p12) cluster near PARK3 at 2p13 (also known as SPR gene and is implicated in dopamine synthesis and early onset Parkinson's disease.) MAT2A is methionine adenosyltransferase II alpha, KIAA0582 is brain K/Na hyper-polarization activated gated channel, a kinase anchor protein, and ARHB as mentioned above is a small guanosine triphosphatase Rho protein that regulates actinfilament remodeling. Prior to the use of Microarray studies, 103 tabulated genes were in the following categories: Receptors, Transcription factors, Enzymes, Neuropeptides, Apoptotic genes, Cytokines, G proteins, Transporters, Growth factors, HIV-related genes, and Heat shock proteins (82) . This overlaps categories identified through Microarray analysis, however, a wider range of types of genes were identified more recently including signaling, genome maintenance, RNA and viral RNA induced, nuclear pore, electron transport, cell cycle, endocytic traffic, proteasome, and most importantly gene directly involved in neuropsychiatric disease.
Transcription insulation is a current concept in molecular biology. The hypothesis is that there are transcription insulators between genes on chromosomes so that gene expression activation does not spill over indiscriminately across the chromosome. Thus, as chromatin conditions or states change there are barriers at various junctions between various gene groups. It remains to be determined how widespread this phenomenon is across all the human chromosomes (93) . This may be related to a mechanics of imprinting, the regulation of expression on paternal vs. maternal autosomal alleles. This exists for example on chromosome 11, at region 11p15.5 for genes H19DMR and intron 10 of gene KCNQ1. Gene insulators and silencers appear are involved and a protein common to each site is CTCF protein that may mediate this control (94) .
That implies that when we find groups of genes that are coordinately expressed that they may be located on the same chromosome and may be even near each other. Thus, the molecular biology term, transcription insulator boundary, could also be termed a gene expression fire wall. This is an alternative to metabolic or signaling networks, genes that are also controlled in concert.
Hypothesis 2. Drug abuse and HIV-1 proteins coerce transcription overload
We hypothesize that the deleterious effects on neurons (in culture and brain) caused by abused drugs and HIV-1 proteins include mechanisms that trigger imbalanced transcription or what we term transcription overload. This overload is due to the coerced expression caused by the treatments that may result in damage to the chromosome's control and organization of the chromatin machinery for transcription. The normal homeostatic checks and balances of the neuron are disrupted to an extent that damages the cell's transcription machinery. Cocaine causes DNA strand breaks and this has been supposed due to its induction of apoptosis (95.) However, we suggest that DNA strand scissions may also result from weakening of chromosome integrity due to coerced and dysregulated transcription. Further investigation is required to dissect and confirm mechanisms of drug and HIV-1 protein effects on human neurons as a model for NeuroAIDS in the context of drug abuse.
CONCLUSIONS AND FUTURE DIRECTIONS
This preliminary work adds a larger dimension and scope to our prior studies that supported the notion that multiple types of analyses are needed for Microarray work (70, 73, 74, 75) . We find that gene expression differs significantly across different treatment conditions (preparations) , that treatments show significant interactive effects on gene expression, that expression of genes varies in groups in parallel across different treatment conditions, and there are specific genes that show gene by treatment effects within these groups. We also find that the genes identified in our study are arranged on the human chromosomes in a non-stochastic fashion, and possibly linked to genes known to be associated with human neuropsychiatric illness. Furthermore, this work lead to hypotheses relating to both transcription isolation and overload in damage due to drug abuse and HIV infection. This emboldens our approach and supports its productive scope.
Currently, we are performing laser capture dissection (LCM) to analyze gene expression in neurons from AIDS brain tissue with and without HIV encephalitis and with and without dementia using Microarray analysis. In addition, we are applying representations of data, processes, and queries to develop detailed tools to assist in the development of automated tools for simulating complex biological processes. Furthermore, we are applying intuitive and programmatic network approaches, cluster methodologies, and to identify key genes and genecombinations in the pathogenesis of dementia due to HIV-1 infection and drug abuse. The application of gene expression, pathway and gene-chromosome architecture analysis are thus productive in this regard. 
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